期刊文献+

Severity evaluation value of serum myeloperoxidase content detection in patients with acute coronary syndrome 被引量:1

在线阅读 下载PDF
导出
摘要 Objective:To analyze the value of serum myeloperoxidase content detection for severity evaluation in patients with acute coronary syndrome.Methods: Acute coronary syndrome (ACS) group included 32 cases, stable angina pectoris (SAP) group included 46 cases, levels of myeloperoxidase (MPO), inflammatory factors and lipid metabolism indexes in serum were compared, coronary echocardiography blood flow parameters were detected, and the correlation between MPO and ACS severity-associated indexes was further analyzed.Results:MPO content in serum of ACS group was significantly higher than those of SAP group and control group;inflammatory factors hs-CRP, IL-6, MCP-1 and LP-PLA2 content in serum were higher than those of SAP group and control group while IL-13 and TGFβ content were lower than those of SAP group and control group;lipid metabolism indexes TC, TG, LDL-C, ApoAI and ApoB content in serum were higher than those of SAP group and control group while HDL-C content was lower than that of SAP group and control group;ultrasonic coronary blood flow parameters SPV, DPV, A, CFVR and CTVⅠ levels were lower than those of SAP group and control group. The serum MPO content in patients with ACS was directly correlated with the content of inflammatory factors and lipid metabolism indexes as well as thelevels of coronary blood flow parameters.Conclusions:Serum MPO content in patients with ACS is directly correlated with the disease severity, and can be used as a reliable index for long-term guide of treatment and prediction of treatment outcome.
出处 《Journal of Hainan Medical University》 2017年第1期37-40,共4页 海南医学院学报(英文版)
作者简介 Corresponding author:Zhao-Di Xie,Laboratory Department,No.2891,Qilianshan Road,Baoshan District,Shanghai,200444,China.Tel:13761496639
  • 相关文献

二级参考文献43

  • 1Franchi F, Rollini F, Cho JR,et al. Platelet function testing in con- temporary clinical and interveutional practice [ J ]. Current Treatment Options in Cardiovascular Medicine,2014,16 ( 5 ) : 300-305.
  • 2中华医学会心血管病学分会.2012中华医学会非ST段抬高急性冠状动脉综合征诊断和治疗指南[J].中华心血管病杂志,2012,40(5):352-367.
  • 3Samardzic J, Krpan M, Skoric B,et al. Serial elopidogrel dose adjust- ment after platelet function testing improves outcome of acute coronary syndrome patients undergoing percutaneous coronary intervention with high on-treatment platelet reactivity [ J ]. Journal of Thrombosis and Thrombolysis ,2014 ,38( 4 ) :459-469.
  • 4Sawada T, Shinke T, Shite J, et al. Impact of cytochrome P450 2C19 * 2 polymorphism on intra - stent thrombus after drug - eluting stent implantation in Japanese patients receiving clopidogrel [ J ]. Circ J, 2011, 75 (1): 99-105.
  • 5Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST - segment elevation : the Task Force for the management of acute coronary syndromes (ACS) irr patients presenting without persistent ST - segment elevation of the European Society of Cardiology (ESC) [J]. EurHeartJ, 2011, 32 (23): 2999-3054.
  • 6World Health Organization. Definition, diagnosis and classifications of diabetes mellitus and its complications. Report of a WHO consultation, Part 1: diagonsis and classification of diabetes mellitus [ S ]. Geneva: WHO, 1999.
  • 7Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non - ST - segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee on the Management of Patients With Unstable Angina) [J]. J Am Coil Cardiol, 2000, 36 (3): 970 - 1062.
  • 8Krintus M, Kozinski M, Kubica J, et al. Critical appraisal of inflammatory markers in cardiovascular risk stratification [ J ]. Crit Rev Clin Lab Sci, 2014, 51 (5) : 263 -279.
  • 9Mazzone T, Chait A, Plutzky J. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies [ J 1. Lancet, 2008, 371 (9626) : 1800 -1809.
  • 10Caixeta A, Stone GW, Mehran R, et al. Predictive value of C - reactive protein on 30 - day and 1 .- year mortality in acute coronary syndromes: an analysis from the ACUITY trial [ J]. J Thromb Thrombolysis, 2011, 31 (2) : 154-164.

共引文献91

同被引文献1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部